Show/hide contentOpenClose All
Curricular information is subject to change
On completion of this module students should be able to:
1. Understand the basis of getting nucleic acid into cells and for using viruses as vectors for gene delivery and as vaccines
2. Describe the main viral vectors in clinical use and the methods by which they are produced industrially
3. Understand how gene therapies can be used in vivo and ex vivo to modify patient cells including using gene editing tools
4. Discuss the different analytical challenges and technologies associated with viral gene therapy characterisation
5. Understand the mode-of-action of different non-viral gene therapies and RNA-based vaccines
6. Describe the manufacturing processes involved in non-viral therapies and associated analytics
| Student Effort Type | Hours |
|---|---|
| Lectures | 16 |
| Autonomous Student Learning | 104 |
| Total | 120 |
Not applicable to this module.
| Description | Timing | Component Scale | % of Final Grade | ||
|---|---|---|---|---|---|
| Multiple Choice Questionnaire: MCQ throughout semester Grading will be non-standard linear scale: % A+ ≥95 100 A ≥90 <95 A- ≥85 <90 B+ ≥80 <85 B ≥75 <80 B- ≥70 <75 C+ ≥65 <70....etc |
Throughout the Trimester | n/a | Alternative linear conversion grade scale 40% | No | 100 |
| Remediation Type | Remediation Timing |
|---|---|
| In-Module Resit | Prior to relevant Programme Exam Board |
• Feedback individually to students, post-assessment
• Online automated feedback
Not yet recorded.